Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
54.28
56.78
294.29
210.87
576.90
797.01
Shareholder's Funds
54.28
56.78
294.29
210.87
576.90
797.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
129.17
111.62
6.00
10.99
12.43
6.65
Secured Loans
129.17
111.62
6.00
10.99
12.43
6.65
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
-8.18
-2.26
Other Long Term Liabilities
16.66
30.18
5.36
3.22
15.46
31.3
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
1.81
0.01
8.53
23.05
Total Non-Current Liabilities
138.55
136.67
5.36
3.22
15.46
31.29
Current Liabilities
Trade Payables
18.17
15.03
28.22
35.70
136.13
80.99
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
1.81
0.01
8.53
23.05
Total Current Liabilities
51.35
44.93
85.67
225.29
354.40
165.18
Total Liabilities
244.19
238.38
385.32
439.38
946.76
993.49
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
37.51
42.55
25.92
28.81
40.99
18.20
Less: Accumulated Depreciation
10.39
7.92
5.49
4.07
2.66
1.01
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
27.11
34.63
20.44
24.74
38.33
17.19
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.85
0.85
0.85
3.62
1.03
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
31.61
35.48
21.29
27.00
51.96
22.60
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
4.37
2.42
0.00
0.00
8.66
0.00
Sundry Debtors
7.29
2.19
0.67
11.87
0.00
0.00
Cash and Bank
178.54
173.41
344.51
362.19
840.25
926.19
Other Current Assets
196.44
193.74
361.78
400.18
872.15
933.16
Short Term Loans and Advances
6.24
15.71
16.59
26.12
0.00
0.00
Total Current Assets
212.58
202.90
364.03
412.37
894.80
970.89
Net Current Assets (Including Current Investments)
161.23
157.97
278.36
187.08
540.40
805.71
Total Current Assets Excluding Current Investments
212.58
202.90
364.03
412.37
894.80
970.89
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
244.19
238.38
385.32
439.38
946.76
993.49
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
129.17
111.62
6.00
10.99
12.43
6.65
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of Oncopeptides AB
Figures in Million
Consolidated - Balance Sheet Results
Change(SEK)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
54.28
208.54
-154.26
-73.97%
Shareholder's Funds
54.28
208.54
-154.26
-73.97%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
129.17
162.14
-32.97
-20.33%
Secured Loans
129.17
162.14
-32.97
-20.33%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
16.66
29.58
-12.92
-43.68%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
138.55
95.95
42.60
44.40%
Current Liabilities
Trade Payables
18.17
242.57
-224.40
-92.51%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
51.35
537.94
-486.59
-90.45%
Total Liabilities
244.19
842.43
-598.24
-71.01%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
37.51
103.48
-65.97
-63.75%
Less: Accumulated Depreciation
10.39
38.58
-28.19
-73.07%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
27.11
64.90
-37.79
-58.23%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
3.94
-3.94
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
31.61
236.53
-204.92
-86.64%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
4.37
246.90
-242.53
-98.23%
Sundry Debtors
7.29
16.85
-9.56
-56.74%
Cash and Bank
178.54
124.33
54.21
43.60%
Other Current Assets
196.44
464.10
-267.66
-57.67%
Short Term Loans and Advances
6.24
76.01
-69.77
-91.79%
Total Current Assets
212.58
605.90
-393.32
-64.92%
Net Current Assets (Including Current Investments)
161.23
67.96
93.27
137.24%
Total Current Assets Excluding Current Investments
212.58
605.90
-393.32
-64.92%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
244.19
842.43
-598.24
-71.01%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
129.17
162.14
-32.97
-20.33%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period






